Reduction in Hospitalizations for Pneumonia Associated With the Introduction of a Pneumococcal Conjugate Vaccination Schedule Without a Booster Dose in Australia
Background: Postmarketing surveillance of heptavalent pneumococcal conjugate vaccine (7vPCV) has shown significant reductions in admissions coded as pneumonia in countries where a booster dose is given in the second year of life. In Australia, a 3-dose primary schedule at 2, 4, and 6 months of age without a booster has been funded nationally for non-Indigenous children since 2005. Methods: All hospital discharges in Australia with the primary diagnosis coded as pneumonia between July 1998 and...[Show more]
|Collections||ANU Research Publications|
|Source:||The Pediatric Infectious Disease Journal|
|01_Jardine_Reduction_in_Hospitalizations_2010.pdf||308.76 kB||Adobe PDF|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.